Inner life of cells under investigation
WashU biomedical engineer Yifan Dai will study chemical processes in cells thanks to a $2 million NIH grant.
AI platform reduces paperwork for WashU Medicine and BJC physicians
WashU Medicine and BJC doctors can now focus less on note-taking and more on interacting with patients with the aid of an AI transcriber.
Bursky Public Health names first FARM distinguished professors
Nutrition scientist Lora Iannotti and engineer Feng Jiao become inaugural Lauren and Lee Fixel Distinguished Professors, advancing interdisciplinary solutions for food, agriculture and health.
Miller honored with Potamkin Prize for dementia research
WashU Medicine neurologist Timothy M. Miller, MD, PhD, has received the 2026 Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Diseases, one of the most prestigious international honors in dementia research.
Gut bacteria linked to malnutrition may pass to younger generations
A new study led by WashU Medicine researchers including Jeffrey I. Gordon, MD, suggests that an intestinal disorder linked to malnutrition and stunted growth may be transmitted from one generation to the next via the small intestine’s microbiome.
New comprehensive data platform could transform Alzheimer’s research, treatment
Researchers at WashU Medicine and the Knight Alzheimer’s Disease Research Center led the development of a scalable platform that links research, real-world patient data and genetic data to uncover new insights into Alzheimer’s disease diagnosis, prevention and care.
Lenschow named inaugural John S. Daniels Professor
Deborah J. Lenschow, MD, PhD, a pioneering scientist who has made significant contributions to the fields of immunology, rheumatology and medicine, has been installed as the inaugural John S. Daniels Professor at WashU Medicine.
Bursky Public Health earns accreditation
Bursky Public Health met all 36 accreditation criteria while documenting a new institution still taking shape behind the scenes.
DNA damage can trigger neurons to self-destruct
WashU Medicine researchers identified key details of how DNA damage can flip a nerve cell’s self-destruct switch. The new study could lead to novel routes to preventing neurodegeneration in a variety of diseases.
Aid for brain-bleed recovery receives FDA Breakthrough Device Designation
An earbud-like device from Aurenar, a WashU startup, is designed to improve stroke outcomes after a ruptured brain aneurysm. The technology is based on clinical trials led by WashU Medicine physician-scientists including Eric Leuthardt, MD.
Older Stories